Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
K. B. Gordon*, A. B. Gottlieb, R. G. Langely, P. Van De Kerkhof, K. T. Belasco, M. Sundaram, M. Okun, L. Serra
Dive into the research topics of 'Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption'. Together they form a unique fingerprint.